Patients okay with doctors disclosing pharma payments

A Galaxy Research survey conducted on behalf of GSK and released yesterday confirmed consumers were worried about the impact of pharmaceutical sponsorships but were much more accepting of the practice when the purpose of the funding was explained.

More than half of the 1007 Australians aged between 18 and 64 surveyed were concerned pharmaceutical sponsorship might compromise a doctor’s integrity (54%), lead to patients not receiving the best medicine (52%) or influence a GP’s advice (72%).

Most respondents (90%) had negative views about pharmaceutical company payments to health practitioners, but 79% approved of funding for medical research programs and 82% approved of funding for some aspect of the health system when the purpose is explained.

GSK healthcare environment director David Herd said pharmaceutical sponsorship for GPs who attended educational events or provided expert advice was about recognition for their time.